NCT06885489

Brief Summary

Mental health is essential for students' emotional, cognitive, and social well-being. University life presents significant academic, social, and financial challenges, leading to increased stress, anxiety, and depression. These psychological difficulties negatively impact students' academic performance, relationships, and overall quality of life. Despite these challenges, many students avoid seeking professional help. Acceptance and Commitment Therapy (ACT) is an effective approach that enhances psychological resilience and helps individuals cope with stress, anxiety, and depression. Instead of changing negative thoughts, ACT fosters psychological flexibility, encouraging individuals to develop a healthier relationship with them. Research supports ACT's effectiveness in reducing psychological distress, improving emotional regulation, and enhancing life satisfaction

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 12, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 20, 2025

Completed
Last Updated

March 20, 2025

Status Verified

March 1, 2025

Enrollment Period

1 month

First QC Date

March 12, 2025

Last Update Submit

March 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Depression, Anxiety and Stress Scale (DASS-21)

    DASS-21 is the short version of the Depression, Anxiety and Stress Scale-42 (DASS-42) developed by Lovibond and Lovibond. The Turkish adaptation of the scale was made by Sarıçam. The 4-point Likert-type scale includes a total of 21 items consisting of three sub-dimensions: depression, anxiety and stress. In the normal sample, test-retest reliability coefficients were found to be r=0.68 for depression, r=0.66 for anxiety and r=0.61 for stress. An individual's score of 5 and above on the depression sub-scale, 4 and above on the anxiety sub-scale and 8 and above on the stress sub-scale is interpreted as indicating the relevant psychological problem.

    8 week

Study Arms (2)

ACT Intervention Group

EXPERIMENTAL

The group receiving Acceptance and Commitment Therapy (ACT)-based intervention.

Behavioral: Acceptance and Commitment Therapy (ACT) based psychoeducation program

Control Group

NO INTERVENTION

No intervention group

Interventions

This study implements an ACT-based psychological intervention designed to enhance psychological well-being and reduce depression, anxiety, and stress among university students. The intervention consists of structured sessions focusing on psychological flexibility, mindfulness, acceptance, and value-driven actions. Participants engage in experiential exercises, cognitive defusion techniques, and behavioral commitment strategies. The intervention is delivered over 8 weeks, with weekly sessions lasting approximately 40 minutes. The sessions are conducted in groups by trained professionals.

ACT Intervention Group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • ust be currently enrolled as a full-time student at a university.

You may not qualify if:

  • Individuals with significant cognitive impairments or those unable to understand the study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atatürk Üniversitesi

Erzurum, Ağrı, 04100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Mental DisordersAnxiety DisordersPsychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 20, 2025

Study Start

January 15, 2025

Primary Completion

February 28, 2025

Study Completion

March 10, 2025

Last Updated

March 20, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations